Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 30 October 2019, 08:18 HKT/SGT
Share:
    

Source: Hitachi, Ltd.
Proton Therapy Opens at Sibley Memorial Hospital, a Member of Johns Hopkins Medicine, US Top-Ranked Healthcare Institution

TOKYO, Oct 30, 2019 - (JCN Newswire) - Hitachi, Ltd. (TSE:6501) has announced that Hitachi has provided its advanced proton therapy system to Sibley Memorial Hospital (Washington DC, US), a member of Johns Hopkins Medicine (Maryland, US), and it has started treatment on October 25, 2019. On October 28, an opening ceremony at Sibley Memorial Hospital was held.




The proton therapy system installed at Sibley includes spot scanning technology that sends a therapeutic proton beam precisely conforming to the shape of the target tumor. It has three rotating gantry treatment rooms and one fixed beam research room. This is the first Hitachi system in the US with Real-time Gated Proton Therapy capability, which allows real-time beam irradiation to the tumor while compensating for movement associated with respiration.

Johns Hopkins Medicine, based in Baltimore, Maryland, US, is a world-class hospital focusing on medical research and clinical care. Johns Hopkins Hospital has maintained its position as one of the top hospitals in U.S. News & World Report rankings for decades. Sibley Memorial Hospital, an affiliate of Johns Hopkins Medicine, provides cancer care from the world-renowned Johns Hopkins

Sidney Kimmel Comprehensive Cancer

Center which also has one of the most successful cancer research programs in the world.
Hitachi has been proactively promoting particle therapy system business worldwide, supplying world-class facilities with its highly reliable and proven particle therapy systems, which have treated more than 60,000 patients. Hitachi will provide system and services, including single room solution in realizing installation in urban limited areas and hybrid system combined with capability of generating both proton and heavy-ion in one accelerator, to meet all customer needs.

Hitachi will continue to accelerate the globalization of its particle therapy system business and contribute to cancer treatment around the world.

* U.S. News & World Report releases its Best Hospitals rankings in the country every year.

Overview of Particle Therapy

Particle Therapy is an advanced type of cancer radiotherapy. Protons extracted from hydrogen atoms, or carbon ions are accelerated up to 70% of the speed of light. This energy is concentrated directly on the tumor while minimizing radiation dose to surrounding healthy tissue. Particle therapy improves the quality of life for cancer patients since the patient experiences no pain during treatment and the procedure has very few side effects compared to that of traditional radiotherapy. In most cases, patients can continue with their normal daily activities while undergoing treatment.

For more information on Hitachi's Particle Therapy System
http://www.hitachi.com/businesses/healthcare/products-support/pbt/


About Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501), headquartered in Tokyo, Japan, delivers innovations that answer society's challenges, combining its operational technology, information technology, and products/systems. The company's consolidated revenues for fiscal 2017 (ended March 31, 2018) totaled 9,368.6 billion yen ($88.4 billion). The Hitachi Group is an innovation partner for the IoT era, and it has approximately 307,000 employees worldwide. Through collaborative creation with customers, Hitachi is deploying Social Innovation Business using digital technologies in a broad range of sectors, including Power/Energy, Industry/Distribution/Water, Urban Development, and Finance/Social Infrastructure/Healthcare. For more information on Hitachi, please visit the company's website at http://www.hitachi.com.

Contact:
Hitachi Ltd
Corporate Communications
Tel: +81-3-3258-1111


Oct 30, 2019 08:18 HKT/SGT
Source: Hitachi, Ltd.

Hitachi, Ltd. (TSE: 6501)

Topic: Press release summary
Sectors: BioTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2020 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Hitachi, Ltd. Links

http://www.hitachi.com

https://www.facebook.com/hitachi.global/

https://twitter.com/hitachiglobal?lang=en

https://www.youtube.com/user/HitachiBrandChannel

https://ph.linkedin.com/company/hitachi

Hitachi, Ltd.
Jan 17, 2020 12:45 HKT/SGT
Hitachi Industrial Products Received "EN 15085 Certificate" for Welding of Railway Vehicles and Components
Jan 17, 2020 08:33 HKT/SGT
Hitachi Completes Construction of H1 TOWER, One of World's Tallest Elevator Test Towers, at R&D and Manufacturing Facility in Guangzhou, China
Jan 17, 2020 08:07 HKT/SGT
Hitachi Joined WIPO GREEN as a Contributing Partner
Jan 10, 2020 19:12 HKT/SGT
Hitachi's Omika Works Recognized as an "Advanced 4th Industrial Revolution Lighthouse" by the World Economic Forum
Dec 26, 2019 12:12 HKT/SGT
Hitachi Automotive Systems Develops Stereo Camera Enabling Automatic Emergency Braking at Intersections
Dec 20, 2019 17:14 HKT/SGT
Hitachi Rail STS Selected for the Modernization of France's Paris-Lyon High-Speed Line
Dec 6, 2019 18:16 HKT/SGT
Hitachi to Provide CNAO with Proton Therapy System
Dec 6, 2019 18:02 HKT/SGT
First Trenitalia Chooses Hitachi Rail to Build New Intercity Trains for Avanti West Coast
Dec 3, 2019 11:31 HKT/SGT
Hitachi: Power Grid Protection System Starts its Demonstration Operation in Poland
Nov 27, 2019 11:52 HKT/SGT
Hitachi Developed Automation Technology of 3D Culture to Expand Regenerative Medicine Business
More news >>
 News Alerts
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 400 879 3881 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 6859 8575

Connect With us: